デフォルト表紙
市場調査レポート
商品コード
1632590

米国のPRP・幹細胞による脱毛症治療市場:市場規模・シェア・動向分析 (治療法別・適応症別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)

U.S. PRP And Stem Cell Alopecia Treatment Market Size, Share & Trends Analysis Report By Treatment (Platelet Rich Plasma Therapy, Stem Cell Therapy), By Indication (Androgenic Alopecia, Alopecia Areata), By End-use, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 70 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
米国のPRP・幹細胞による脱毛症治療市場:市場規模・シェア・動向分析 (治療法別・適応症別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)
出版日: 2024年12月31日
発行: Grand View Research
ページ情報: 英文 70 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のPRP・幹細胞による脱毛症治療市場の成長と動向:

Grand View Research社の最新レポートによると、米国のPRP・幹細胞による脱毛症治療の市場規模は、2030年までに4億3,891万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR 9.46%で成長すると予測されています。同市場の成長要因には、疾患認知度の上昇、治療率の向上、患者に良好な転帰をもたらす新規治療法の採用拡大などがあります。さらに、この療法による副作用の発生率が低いことが、多血小板血漿 (PRP) 療法と幹細胞療法の需要を促進すると予測されています。

脱毛症に対するPRPや幹細胞療法の採用は、従来の治療法よりも新規の治療法を好む患者の増加により増加すると予想されます。これに加えて、治療期間の短縮、発毛の早さ、患者の予後の改善が、予測期間中にこれらの治療法の需要を促進すると予想されます。

治療法の種類別では、PRP処置が処置件数ベースで2017年に58.1%の最大シェアを占めました。しかし、PRP処置の価格が低いため、幹細胞治療処置が2017年に支配的な収益シェアを占め、7,010万米ドルと評価されました。最終用途別では、病院と比較して治療費が低いことから、皮膚科クリニックセグメントが2017年の総市場収益の85.0%を占めました。

競合情勢には、Orange County Hair Restoration Center、Hair Sciences Center of Colorado、Evolution Hair Loss Institute、Savola Aesthetic Dermatology Center、PLC、NovaGenix、Virginia Surgical Center、Hair Transplant Institute of Miamiなどのクリニックが含まれます。

米国のPRP・幹細胞による脱毛症治療市場:分析概要

  • 幹細胞治療は、脱毛や退行性疾患を含む様々な症状の治療への応用が期待されることから、予測期間中にCAGR 12.47%で大きく成長する見込みです。
  • 男性型脱毛症が市場を席巻し、2024年には71.51%の最大売上シェアを占めましたが、これは有病率が高く、男性約5,000万人、女性約3,000万人が罹患しているためです。
  • 皮膚科クリニックが市場を独占し、2024年には69.60%の最大売上高シェアを占めましたが、これは男性型脱毛症などの皮膚疾患や脱毛症の有病率が上昇していることによります。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 米国のPRP・幹細胞による脱毛症治療市場:変動要因・傾向・範囲

  • 市場概要/連関の見通し
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 米国のPRP・幹細胞による脱毛症治療市場:分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国のPRP・幹細胞による脱毛症治療市場:治療法別の推定・動向分析

  • セグメントダッシュボード
  • 米国のPRP・幹細胞による脱毛症治療市場:変動分析、治療法別 (2023年・2030年)
  • 多血小板血漿療法
  • 幹細胞療法

第5章 米国のPRP・幹細胞による脱毛症治療市場:適応症別の推定・動向分析

  • セグメントダッシュボード
  • 米国のPRP・幹細胞による脱毛症治療市場:変動分析、適応症別 (2023年・2030年)
  • 男性型脱毛症
  • 円形脱毛症
  • 瘢痕性脱毛症
  • その他

第6章 米国のPRP・幹細胞による脱毛症治療市場:最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 米国のPRP・幹細胞による脱毛症治療市場:変動分析、最終用途別 (2023年・2030年)
  • 病院
  • 皮膚科クリニック
  • その他

第7章 競合情勢

  • 最新動向と影響分析:主な市場参入企業別
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Bauman Medical Group, PA
    • Virginia Surgical Center
    • Nova Medical Hair Transplant
    • Chicago Hair Transplant Clinic
    • Dr. V Medical Aesthetics
    • City Facial Plastics
    • Orange County Hair Restoration
    • MAXIM Hair Restoration
    • New Jersey Hair Restoration Center
    • Hair Restoration Institute of Minnesota
    • Morgenstern Hair Restoration LLC.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. PRP & Stem Cell Alopecia Treatment Market, by Treatment, 2018 - 2030 (USD Million)
  • Table 4 U.S. PRP & Stem Cell Alopecia Treatment Market, by Indication, 2018 - 2030 (USD Million)
  • Table 5 U.S. PRP & Stem Cell Alopecia Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Key companies undergoing collaboration and partnerships
  • Table 7 Key companies using other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 U.S. PRP & Stem Cell Alopecia Treatment Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis
  • Fig. 16 U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Outlook and Key Takeaways
  • Fig. 17 PRP Therapy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 18 Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 19 U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis
  • Fig. 20 U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Outlook and Key Takeaways
  • Fig. 21 Androgenic Alopecia Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 22 Alopecia Areata Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 23 Cicatricial Alopecia Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 24 Other Indications Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis
  • Fig. 26 U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Outlook and Key Takeaways
  • Fig. 27 Dermatology Clinics Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Other End Use Market Estimates and Forecasts, 2018 - 2030
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 U.S. PRP & Stem Cell Alopecia Treatment Market Movement Analysis by Region
目次
Product Code: GVR-2-68038-594-6

U.S. PRP And Stem Cell Alopecia Treatment Market Growth & Trends:

The U.S. PRP and stem cell alopecia treatment market size is anticipated to reach USD 438.91 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.46% from 2025 to 2030. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.

Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.

By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.

The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.

U.S. PRP And Stem Cell Alopecia Treatment Market Report Highlights:

  • Stem cell therapy is expected to grow significantly at a CAGR of 12.47% over the forecast period, owing to its promising applications in treating various conditions, including hair loss and degenerative diseases.
  • Androgenic alopecia dominated the market and accounted for the largest revenue share of 71.51% in 2024 attributed to its high prevalence, affecting approximately 50 million men and 30 million women.
  • Dermatology clinics dominated the market and accounted for the largest revenue share of 69.60% in 2024 driven by the rising prevalence of skin conditions and hair loss disorders, such as androgenic alopecia.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. PRP & Stem Cell Alopecia Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1 Increasing Prevalence of Alopecia
      • 3.3.1.2 Technological Advancements and Research in Regenerative Medicine
      • 3.3.1.3 Increasing Consumer Demand for Non-Invasive and Natural Treatments
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Regulatory and Legal Barriers
      • 3.3.2.2. High Cost of Treatment and Accessibility Issues
      • 3.3.2.3. Lack of Long-Term Clinical Evidence and Efficacy Data
  • 3.4. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Platelet Rich Plasma Therapy
    • 4.3.1. Platelet Rich Plasma Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Stem Cell Therapy
    • 4.4.1. Stem Cell Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Androgenic Alopecia
    • 5.3.1. Androgenic Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Alopecia Areata
    • 5.4.1. Alopecia Areata Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cicatricial or Scarring Alopecia
    • 5.5.1. Cicatricial or Scarring Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Dermatology Clinics
    • 6.4.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Other Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Bauman Medical Group, P.A.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Product Benchmarking
      • 7.4.1.3. Recent Developments/ Strategic Initiatives
    • 7.4.2. Virginia Surgical Center
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Product Benchmarking
      • 7.4.2.3. Recent Developments/ Strategic Initiatives
    • 7.4.3. Nova Medical Hair Transplant
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Recent Developments/ Strategic Initiatives
    • 7.4.4. Chicago Hair Transplant Clinic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Recent Developments/ Strategic Initiatives
    • 7.4.5. Dr. V Medical Aesthetics
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Recent Developments/ Strategic Initiatives
    • 7.4.6. City Facial Plastics
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Product Benchmarking
      • 7.4.6.3. Recent Developments/ Strategic Initiatives
    • 7.4.7. Orange County Hair Restoration
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Product Benchmarking
      • 7.4.7.3. Recent Developments/ Strategic Initiatives
    • 7.4.8. MAXIM Hair Restoration
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Recent Developments/ Strategic Initiatives
    • 7.4.9. New Jersey Hair Restoration Center
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Recent Developments/ Strategic Initiatives
    • 7.4.10. Hair Restoration Institute of Minnesota
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Recent Developments/ Strategic Initiatives
    • 7.4.11. Morgenstern Hair Restoration LLC.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Product Benchmarking
      • 7.4.11.3. Recent Developments/ Strategic Initiatives